Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Observational and Prospective Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 Inhibitors (MEMOGAL)

NCT04319081 is registered in ClinicalTrials.gov with Jose Seijas Amigo as lead sponsor.

NCT NCT04319081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04319081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Observational and Prospective Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 Inhibitors (MEMOGAL)
Lead sponsor
Jose Seijas Amigo
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
January 13, 2023
Enrollment
180 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive function, hypercholesterolemia, quality of life